[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100641994":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":36,"centralContacts":45,"locations":55,"responsibleParty":71,"collaborators":30,"id":72,"slug":73,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":78,"eligibilityCriteria":79,"healthyVolunteers":74,"sex":80,"minAge":81,"maxAge":82,"enrollmentInfo":83,"targetDuration":30,"studyType":86,"phases":87,"briefSummary":89,"conditions":90,"keywords":93,"overallStatus":58,"whyStopped":30,"lastUpdateSubmitDate":108,"lastUpdatePostDateStruct":109,"startDateStruct":112,"completionDateStruct":114,"leadSponsor":116,"locationsCount":117},{"fullName":5,"class":6},"Clinical Center of Vojvodina","OTHER",[8,14,20],{"label":9,"type":10,"description":11,"interventionNames":12},"VACUTEX™ group","EXPERIMENTAL","Patients receive wound care using the VACUTEX™ capillary action dressing system with dressing changes performed every 4 days until wound closure (suture removal).",[13],"Device: VACUTEX™ wound dressing",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard dressing - 3-day change","ACTIVE_COMPARATOR","Patients receive standard wound care using Octenisept® solution with sterile dressing, with dressing changes performed every 3 days until wound closure (suture removal).",[19],"Procedure: Octenisept® wound care dressing",{"label":21,"type":16,"description":22,"interventionNames":23},"Standard dressing - 2-day change","Patients receive standard wound care using Octenisept® solution with sterile dressing, with dressing changes performed every 2 days until wound closure (suture removal).",[19],[25,31],{"type":26,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"DEVICE","VACUTEX™ wound dressing","A capillary action-based wound management system designed for continuous removal of exudate without the use of external negative pressure, maintaining a moist wound environment and minimizing dressing adherence to the wound surface.",[9],null,{"type":32,"name":33,"description":34,"armGroupLabels":35,"otherNames":30},"PROCEDURE","Octenisept® wound care dressing","Standard postoperative wound care involving application of Octenisept® aqueous solution and sterile dressing for surgical wound management.",[21,15],[37,41],{"name":38,"affiliation":39,"role":40},"Andrijana Ćorić","Faculty of Mediicne, University of Novi Sad","PRINCIPAL_INVESTIGATOR",{"name":42,"affiliation":43,"role":44},"Nemanja Gvozdenović","Faculty of Mediicne, University of Novi Sad; Clinic for Orthopedic Surgery and Traumatology, University Clinical Center of Vojvodina","STUDY_DIRECTOR",[46,51],{"name":47,"role":48,"phone":49,"phoneExt":30,"email":50},"Andrijana Ćorić, MScN","CONTACT","+381611810756","912007d23@mf.uns.ac.rs",{"name":52,"role":48,"phone":53,"phoneExt":30,"email":54},"Nemanja Gvozdenović, PhD, Associate Professor","+381646355614","nemanja.gvozdenovic@mf.uns.ac.rs",[56],{"facility":57,"status":58,"city":59,"state":30,"zip":60,"country":61,"countryCode":62,"cosmosGeoPoint":63,"geoPoint":68,"contacts":69},"Clinic for Orthopedic Surgery and Traumatology, University Clinical Center of Vojvodina","RECRUITING","Novi Sad","21000","Serbia","RS",{"type":64,"coordinates":65},"Point",[66,67],19.83694,45.25167,{"lat":67,"lon":66},[70],{"name":52,"role":48,"phone":53,"phoneExt":30,"email":54},{"type":40,"investigatorFullName":42,"investigatorTitle":42,"investigatorAffiliation":5,"oldNameTitle":30,"oldOrganization":30},"100641994","wound-healing-dressing-type-and-dressing-change-frequency-in-tha-100641994",false,"NCT07655388","Wound Healing, Dressing Type, and Dressing Change Frequency in THA","Impact of Dressing Type and Dressing Change Frequency on Surgical Wound Healing Following Primary Total Hip Arthroplasty","CAP-HIP","Inclusion Criteria:\n\nPatients scheduled for primary total hip arthroplasty (THA) Age ≥ 65 years Ability to provide informed consent Patients with closed surgical incision suitable for standard postoperative wound care\n\nExclusion Criteria:\n\nRevision hip arthroplasty Active infection at the time of surgery Immunosuppressive therapy or severe immunodeficiency Known allergy to dressing materials used in the study Severe peripheral vascular disease affecting wound healing Inability to comply with follow-up protocol","ALL","65 Years","95 Years",{"count":84,"type":85},90,"ESTIMATED","INTERVENTIONAL",[88],"NA","Surgical wound complications following primary total hip arthroplasty remain a significant clinical challenge despite advances in wound care technologies. The optimal choice of dressing and frequency of dressing changes remain insufficiently investigated, particularly regarding their influence on wound healing and the wound microenvironment.\n\nThis prospective, randomized, controlled clinical trial aims to evaluate the impact of dressing type and dressing change frequency on surgical wound healing in patients undergoing primary total hip arthroplasty. Ninety patients will be allocated into three treatment groups receiving either a capillary-action dressing system (VACUTEX™) or standard dressings with different dressing change intervals.\n\nThe study will assess time to complete wound epithelialization, postoperative wound complications, pain intensity, wound temperature, exudate pH, length of hospital stay, and time to suture removal. In addition, the study will investigate the potential role of wound temperature and exudate pH as early indicators of impaired healing and postoperative complications.",[91,92],"Wound Healing Time","Total Hip Arthroplasty (THA)",[94,95,96,97,98,99,100,101,102,103,104,105,106,107],"Wound Dressing","VACUTEX","Dressing Change Frequency","Primary Total Hip Arthroplasty","Surgical Wound","Wound Healing","Exudate pH","Wound Temperature","Postoperative Pain","Orthopedic Surgery","Nursing","Surgical Site Infection","Epithelialization","Wound Care","2026-06-12",{"date":110,"type":111},"2026-06-17","ACTUAL",{"date":113,"type":85},"2026-05-25",{"date":115,"type":85},"2026-09-01",{"name":5,"class":6},1]